Innovation Pharmaceuticals Inc. (IPIX)
OTCMKTS · Delayed Price · Currency is USD
0.0007
-0.0003 (-30.00%)
Feb 12, 2026, 1:49 PM EST

IPIX Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '23 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19
--0.02-0.42-
Gross Profit
--0.02-0.42-
Selling, General & Admin
1.491.481.9622.271.95
Research & Development
0.871.464.817.022.794.34
Operating Expenses
2.362.946.789.025.066.3
Operating Income
-2.36-2.94-6.76-9.02-4.64-6.3
Interest Expense
-0.06-0.06-0.12-4.86-0.26-2.2
Earnings From Equity Investments
-0.21-0.17-0.02---
Other Non Operating Income (Expenses)
---0.18-0.10.36
EBT Excluding Unusual Items
-2.62-3.17-7.07-13.87-4.79-8.14
Asset Writedown
---0.14--0.64-0.15
Other Unusual Items
--0.17--1.21-0.39
Pretax Income
-2.62-3.17-7.04-13.87-6.65-8.68
Net Income
-2.62-3.17-7.04-13.87-6.65-8.68
Net Income to Common
-2.62-3.17-7.04-13.87-6.65-8.68
Shares Outstanding (Basic)
509506504386238178
Shares Outstanding (Diluted)
509506504386238178
Shares Change (YoY)
-1.42%0.38%30.48%61.96%33.78%23.33%
EPS (Basic)
-0.01-0.01-0.01-0.04-0.03-0.05
EPS (Diluted)
-0.01-0.01-0.01-0.04-0.03-0.05
Free Cash Flow
-1.99-2.11-6.28-9.5-4.16-6.33
Free Cash Flow Per Share
-0.00-0.00-0.01-0.03-0.02-0.04
Gross Margin
--100.00%-100.00%-
Operating Margin
---37544.44%--1095.74%-
Profit Margin
---39116.67%--1571.63%-
Free Cash Flow Margin
---34888.89%--982.51%-
EBITDA
-1.99-2.57-6.38-8.64-4.26-5.93
D&A For EBITDA
0.370.370.380.380.370.37
EBIT
-2.36-2.94-6.76-9.02-4.64-6.3
Updated Nov 20, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.